Skip to main content

Kawasaki Disease Diagnosis and Complication Rates in the United States and Japan

  • Chapter
  • First Online:
Kawasaki Disease
  • 1311 Accesses

Abstract

Clear diagnostic criteria and definitions of coronary artery lesions (CALs) were established in Japan by the Japanese Ministry of Health Research Committee (Fifth Revised Edition, February 2002) and the Japanese Circulation Society (JCS), and in the United States by the American Heart Association (AHA) and American Academy of Pediatrics (AAP), in 2004. Definitions and criteria for Kawasaki disease diagnosis slightly differ between the AHA/AAP and Japanese guidelines. The diagnostic criteria for classical Kawasaki disease in AHA/AAP guidelines include fever persisting at least 5 days and at least four of five other criteria. The criteria in the Japanese guidelines include fever as a sixth, equally important criterion, and patients must meet five of six criteria for diagnosis, including fever that subsides within 5 days in response to therapy. It is difficult to compare CAL rates in these countries because the definitions of CALs are completely different in the respective guidelines. The Japanese JCS guidelines for CALs use the diameter of each segment of coronary arteries. However, in the AHA/APP guidelines aneurysms are classified using z-scores. Previously reported differences in CAL rates between the United States and Japan likely resulted from use of different definitions and nomenclature. Development of standard criteria for CALs in both countries would allow meaningful comparisons between countries and facilitate collaborative international clinical trials.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ayusawa M, Sonobe T, Uemura S, Ogawa S, Nakamura Y, Kiyosawa N, et al. Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition). Pediatr Int. 2005;47(2):232–4.

    Article  PubMed  Google Scholar 

  2. Japanese Circulation Society Joint Research Group. Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease. Pediatr Int. 2005;47(6):711–32. http://dx.doi.org/10.1111/j.1442-200x.2005.02149.x PMID:16354233.

    Article  Google Scholar 

  3. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Committee on rheumatic fever, endocarditis and Kawasaki disease; Council on Cardiovascular Disease in the Young; American Heart Association; American Academy of Pediatrics. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 2004;110(17):2747–71. http://dx.doi.org/10.1161/01.CIR.0000145143.19711.78 PMID:15505111.

    Article  PubMed  Google Scholar 

  4. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics. 2004;114(6):1708–33. http://dx.doi.org/10.1542/peds.2004-2182 PMID:15574639.

    Article  PubMed  Google Scholar 

  5. Bayers S, Shulman ST, Paller AS. Kawasaki disease: Part I. Diagnosis, clinical features, and pathogenesis. J Am Acad Dermatol. 2013;69(4):501 e1–11; quiz 11–2.

    Article  PubMed  Google Scholar 

  6. Uehara R, Belay ED. Epidemiology of Kawasaki disease in Asia, Europe, and the United States. J Epidemiol. 2012;22(2):79–85.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Makino N, Nakamura Y, Yashiro M, Ae R, Tsuboi S, Aoyama Y, et al. Descriptive epidemiology of Kawasaki disease in Japan, 2011–2012: from the results of the 22nd nationwide survey. J Epidemiol. 2015;25(3):239–45.

    Article  PubMed  Google Scholar 

  8. Sonobe T, Kiyosawa N, Tsuchiya K, Aso S, Imada Y, Imai Y, et al. Prevalence of coronary artery abnormality in incomplete Kawasaki disease. Pediatr Int. 2007;49(4):421–6. http://dx.doi.org/10.1111/j.1442-200X.2007.02396.x.

    Article  PubMed  Google Scholar 

  9. Yellen ES, Gauvreau K, Takahashi M, Burns JC, Shulman S, Baker AL, et al. Performance of 2004 American Heart Association recommendations for treatment of Kawasaki disease. Pediatrics. 2010;125(2):e234–41. http://dx.doi.org/10.1542/peds.2009-0606 PMID:20100771.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Tremoulet AH, Best BM, Song S, Wang S, Corinaldesi E, Eichenfield JR, et al. Resistance to intravenous immunoglobulin in children with Kawasaki disease. J Pediatr. 2008;153(1):117–21. http://dx.doi.org/10.1016/j.jpeds.2007.12.021 PMID:18571548.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Ogata S, Tremoulet AH, Sato Y, Ueda K, Shimizu C, Sun X, et al. Coronary artery outcomes among children with Kawasaki disease in the United States and Japan. Int J Cardiol. 2013;168(4):3825–8. http://dx.doi.org/10.1016/j.ijcard.2013.06.027 PMID:23849968.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Dallaire F, Dahdah N. New equations and a critical appraisal of coronary artery Z scores in healthy children. J Am Soc Echocardiogr. 2011;24(1):60–74. http://dx.doi.org/10.1016/j.echo.2010.10.004 PMID:21074965.

    Article  PubMed  Google Scholar 

  13. Manlhiot C, Millar K, Golding F, McCrindle BW. Improved classification of coronary artery abnormalities based only on coronary artery z-scores after Kawasaki disease. Pediatr Cardiol. 2010;31(2):242–9. http://dx.doi.org/10.1007/s00246-009-9599-7 PMID:20024653.

    Article  PubMed  Google Scholar 

  14. de Zorzi A, Colan SD, Gauvreau K, Baker AL, Sundel RP, Newburger JW. Coronary artery dimensions may be misclassified as normal in Kawasaki disease. J Pediatr. 1998;133(2):254–8. http://dx.doi.org/10.1016/S0022-3476(98)70229-X PMID:9709715.

    Article  PubMed  Google Scholar 

  15. Belay ED, Maddox RA, Holman RC, Curns AT, Ballah K, Schonberger LB. Kawasaki syndrome and risk factors for coronary artery abnormalities: United States, 1994–2003. Pediatr Infect Dis J. 2006;25(3):245–9. http://dx.doi.org/10.1097/01.inf.0000202068.30956.16 PMID:16511388.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shohei Ogata .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Japan

About this chapter

Cite this chapter

Ogata, S. (2017). Kawasaki Disease Diagnosis and Complication Rates in the United States and Japan. In: Saji, B., Newburger, J., Burns, J., Takahashi, M. (eds) Kawasaki Disease. Springer, Tokyo. https://doi.org/10.1007/978-4-431-56039-5_24

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-56039-5_24

  • Published:

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-56037-1

  • Online ISBN: 978-4-431-56039-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics